Important: IGF-1 LR3 has no human clinical trial data; it is primarily a laboratory research reagent. Claims about human muscle growth or performance are not supported by clinical evidence.
Overview
IGF-1 LR3 (Insulin-like Growth Factor 1 Long Arginine 3) is a recombinant analog of human insulin-like growth factor 1 (IGF-1). It is engineered to have significantly enhanced potency and a dramatically extended half-life compared to the native hormone. The "LR3" designation refers to two key modifications: an N-terminal extension of 13 amino acids and a glutamate-to-arginine substitution at position 3. Native IGF-1 is rapidly sequestered by IGF-binding proteins (IGFBPs) in the circulation, resulting in a half-life of approximately 10–20 minutes. IGF-1 LR3's modifications reduce its affinity for IGFBPs by approximately 1,000-fold. This extends its effective half-life to approximately 20–30 hours and dramatically amplifies its biological activity compared to the native hormone.
Mechanism of Action
IGF-1 LR3 exerts its effects by binding to the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase expressed on virtually all cell types. IGF-1R binding triggers receptor autophosphorylation and activation of two major downstream signaling cascades: the PI3K/Akt pathway and the MAPK/ERK pathway. The PI3K/Akt pathway is the primary mediator of IGF-1's anabolic effects. Akt activation phosphorylates and inhibits FOXO transcription factors, reducing protein catabolism. It also activates mTORC1, stimulating protein synthesis and cell growth, and promotes glucose uptake via GLUT4 translocation. The MAPK/ERK pathway drives cell proliferation and differentiation, particularly in muscle satellite c
Research Evidence
- ~1,000-fold reduced IGFBP binding vs. native IGF-1, extending half-life to ~20–30 hours
- Activates PI3K/Akt/mTORC1 pathway, stimulating protein synthesis and inhibiting catabolism
- MAPK/ERK activation drives muscle satellite cell proliferation and differentiation
- Promotes GLUT4 translocation and enhanced glucose uptake in muscle cells
- Widely used in cell culture optimization to enhance proliferation and viability
Bottom line: IGF-1 LR3 is a potent research compound that operates at the intersection of growth hormone biology, muscle physiology, and metabolic regulation. Its extended half-life makes it a powerful research tool but also means its effects persist much longer than natural IGF-1. It is a research-only compound prohibited by WADA.
Research Protocols & Dosage
Evidence-based research protocols, administration routes, and dosage considerations for IGF-1 LR3 are detailed in the full compound profile. See also: Dosage guide for IGF-1 LR3.
Sourcing & Quality
IGF-1 LR3 is available from Purgo Labs with third-party COA verification and research-grade purity standards. View IGF-1 LR3 at Purgo Labs.